# Goodrx (GDRX) — Analyst Forecast

GDRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/gdrx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 4 | 9 | 2 | 15 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $3.75 | $4.55 | $5.00 | 5 |

Last price $3.51 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 21, 2026 | Barclays | Maintained | Underweight | $4.00 |
| Aug 13, 2026 | UBS | Maintained | Neutral | $3.75 |
| Aug 11, 2026 | TD Cowen | Maintained | Buy | $5.00 |
| Aug 11, 2026 | Citigroup | Maintained | Buy | $5.00 |
| Aug 7, 2026 | Wells Fargo | Maintained | Overweight | $5.00 |
| May 14, 2026 | Citigroup | Maintained | Buy | $4.00 |
| May 11, 2026 | TD Cowen | Maintained | Buy | $4.00 |
| Mar 4, 2026 | Wells Fargo | Maintained | Overweight | $3.50 |
| Mar 3, 2026 | Citigroup | Maintained | Buy | $3.50 |
| Mar 2, 2026 | Goldman Sachs | Maintained | Neutral | $2.50 |
| Feb 27, 2026 | JP Morgan | Downgraded | Overweight → Neutral | — |
| Feb 27, 2026 | Mizuho | Maintained | Neutral | $3.00 |
| Jan 22, 2026 | Jefferies | Downgraded | Buy → Hold | $2.75 |
| Jan 9, 2026 | Citigroup | Maintained | Buy | $4.50 |
| Dec 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | $4.00 |
| Dec 9, 2025 | Barclays | Initiated Coverage | Underweight | $3.00 |
| Nov 11, 2025 | JP Morgan | Maintained | Overweight | $5.00 |
| Nov 10, 2025 | TD Cowen | Maintained | Buy | $6.00 |
| Nov 6, 2025 | Mizuho | Maintained | Neutral | $4.00 |
| Nov 6, 2025 | UBS | Maintained | Neutral | $4.00 |

## Frequently Asked Questions

### What is the price target for GDRX stock?

The average 12-month analyst price target for Goodrx (GDRX) is $4.55, with a high estimate of $5.00 and a low of $3.75, across 5 analysts.

### Is GDRX a buy, sell, or hold?

Analysts covering Goodrx currently average a Hold rating: 4 buy, 9 hold and 2 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for GDRX?

The average price target of $4.55 implies 29.81% upside from the last price of $3.51.

### What is the latest analyst rating on GDRX?

On Aug 21, 2026, Barclays maintained Goodrx at Underweight with a price target of $4.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).